passages.id: 1.0alpha7.train.1127.sent
passages.type: sentence
passages.text: To control for the specificity of 12S E1A-dependent inhibition of Gal-Ets 2-440, we also used a CBP-independent activator, Gal-CREB 160-284, which fuses the Gal DBD to the glutamine-rich activation domain of CREB, termed Q2 (Q2 binds the TFIID component dTAF110 [16, 25, 61, 77]). 
coreferences.id: 1.0alpha7.train.1127.coref0
coreferences.entity_ids: 1.0alpha7.train.1127.ent0_0
coreferences.id: 1.0alpha7.train.1127.coref1
coreferences.entity_ids: 1.0alpha7.train.1127.ent1_0 1.0alpha7.train.1127.ent2_0 1.0alpha7.train.1127.ent3_1
coreferences.id: 1.0alpha7.train.1127.coref2
coreferences.entity_ids: 1.0alpha7.train.1127.ent4_0
coreferences.id: 1.0alpha7.train.1127.coref3
coreferences.entity_ids: 1.0alpha7.train.1127.ent5_0
coreferences.id: 1.0alpha7.train.1127.coref4
coreferences.entity_ids: 1.0alpha7.train.1127.ent6_0
coreferences.id: 1.0alpha7.train.1127.coref5
coreferences.entity_ids: 1.0alpha7.train.1127.ent7_0
coreferences.id: 1.0alpha7.train.1127.coref6
coreferences.entity_ids: 1.0alpha7.train.1127.ent8_0
coreferences.id: 1.0alpha7.train.1127.coref7
coreferences.entity_ids: 1.0alpha7.train.1127.ent9_0 1.0alpha7.train.1127.ent10_1 1.0alpha7.train.1127.ent11_2
coreferences.id: 1.0alpha7.train.1127.coref8
coreferences.entity_ids: 1.0alpha7.train.1127.ent12_0
coreferences.id: 1.0alpha7.train.1127.coref9
coreferences.entity_ids: 1.0alpha7.train.1127.ent13_0
coreferences.id: 1.0alpha7.train.1127.coref10
coreferences.entity_ids: 1.0alpha7.train.1127.ent14_0
coreferences.id: 1.0alpha7.train.1127.coref11
coreferences.entity_ids: 1.0alpha7.train.1127.ent15_0 1.0alpha7.train.1127.ent16_1
coreferences.id: 1.0alpha7.train.1127.coref12
coreferences.entity_ids: 1.0alpha7.train.1127.ent17_0